HR Execs on the Move


 
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.seagen.com
  • 21823, 30th Drive Southeast
    Bothell, WA USA 98021
  • Phone: 425.527.4000

Executives

Name Title Contact Details
Frank Jordan
Director HR Data Reporting and Analytics Profile
Colleen Peterson
Executive Director Human Resources Profile
Stephanie Lam
Associate Director Human Resources, HRBP Profile
Bart Cornelissen
Vice President Corporate Finance Profile
Karen Manalang
Associate Director, Accounting Profile

Similar Companies

Discovery Genomics

Discovery Genomics, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Bryan LGH

Bryan LGH is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biofourmis

Biofourmis is a fast-growing global health IT start-up founded in Singapore that augments personalized patient care and therapies with Digital Therapeutics for better management of patients with complex chronic conditions. The company discovers, develops and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis has built Biovitals™, a highly sophisticated personalized artificial intelligence (AI)-powered health analytics platform that predicts clinical exacerbation days in advance before a critical event. Biovitals™ is the backbone of the company`s Digital Therapeutics product pipeline, which spans a number of therapeutic areas and disease states, including heart failure, acute coronary syndrome, COPD and chronic pain.

DSM

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.

Alamar Biosciences

Alamar Biosciences is a biotechnology company that has developed a next generation proteomic platform with ultra high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.